The joint use of 99mTc-MAA-SPECT/CT and cone-beam CT optimizes radioembolization planning
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2191-219X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The joint use of 99mTc-MAA-SPECT/CT and cone-beam CT optimizes radioembolization planning ; volume:11 ; number:1 ; day:4 ; month:3 ; year:2021 ; pages:1-11 ; date:12.2021
EJNMMI Research ; 11, Heft 1 (4.3.2021), 1-11, 12.2021
- Urheber
-
Rodríguez-Fraile, Macarena
Ezponda, Ana
Grisanti, Fabiana
Morán, Verónica
Calvo, Marta
Berián, Pablo
Cuesta, Antonio Martínez de la
Sancho, Lidia
Iñarrairaegui, Mercedes
Sangro, Bruno
Bilbao, José Ignacio
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13550-021-00764-z
- URN
-
urn:nbn:de:101:1-2021041814355755949759
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rodríguez-Fraile, Macarena
- Ezponda, Ana
- Grisanti, Fabiana
- Morán, Verónica
- Calvo, Marta
- Berián, Pablo
- Cuesta, Antonio Martínez de la
- Sancho, Lidia
- Iñarrairaegui, Mercedes
- Sangro, Bruno
- Bilbao, José Ignacio
- SpringerLink (Online service)
Ähnliche Objekte (12)
Addressing lung truncation in 99mTc-MAA SPECT/CT for 90Y microsphere radioembolization treatment planning
The value of 99mTc-MAA SPECT/CT for lung shunt estimation in 90Y radioembolization: a phantom and patient study
Radioembolization for Hepatocellular Carcinoma: a Comparison on Dual-phase Cone-beam CT, Contrast-enhanced CT (CECT) and 99mTc-macroaggregated albumin-SPECT/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET/CT
Evaluierung von Verteilungsunterschieden zwischen prätherapeutischem 99mTc-MAA SPECT/CT und posttherapeutischem 90Y PET/CT bei der SIRT
Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization
Impact of the dosimetry approach on the resulting 90Y radioembolization planned absorbed doses based on 99mTc-MAA SPECT-CT: is there agreement between dosimetry methods?
Combined quality and dose-volume histograms for assessing the predictive value of 99mTc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer
CT texture features and lung shunt fraction measured using 99mTc-macroaggregated albumin SPECT/CT before trans-arterial radioembolization for hepatocellular carcinoma patients
Correction to: Combined quality and dose-volume histograms for assessing the predictive value of 99mTc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer
Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
Korrelation der Parenchym Blood Volume (PBV)-Rotationsangiographie mit der Technecium-99m Macroaggregated Albumin (99mTc-MAA)-SPECT/CT zur Planung der Selektiven Internen Radiotherapie
Sinus floor elevation : avoiding pitfalls using cone-beam CT
Addressing lung truncation in 99mTc-MAA SPECT/CT for 90Y microsphere radioembolization treatment planning
The value of 99mTc-MAA SPECT/CT for lung shunt estimation in 90Y radioembolization: a phantom and patient study
Radioembolization for Hepatocellular Carcinoma: a Comparison on Dual-phase Cone-beam CT, Contrast-enhanced CT (CECT) and 99mTc-macroaggregated albumin-SPECT/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET/CT
Evaluierung von Verteilungsunterschieden zwischen prätherapeutischem 99mTc-MAA SPECT/CT und posttherapeutischem 90Y PET/CT bei der SIRT
Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization
Impact of the dosimetry approach on the resulting 90Y radioembolization planned absorbed doses based on 99mTc-MAA SPECT-CT: is there agreement between dosimetry methods?
Combined quality and dose-volume histograms for assessing the predictive value of 99mTc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer
CT texture features and lung shunt fraction measured using 99mTc-macroaggregated albumin SPECT/CT before trans-arterial radioembolization for hepatocellular carcinoma patients
Correction to: Combined quality and dose-volume histograms for assessing the predictive value of 99mTc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer
Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
Korrelation der Parenchym Blood Volume (PBV)-Rotationsangiographie mit der Technecium-99m Macroaggregated Albumin (99mTc-MAA)-SPECT/CT zur Planung der Selektiven Internen Radiotherapie
Sinus floor elevation : avoiding pitfalls using cone-beam CT
Addressing lung truncation in 99mTc-MAA SPECT/CT for 90Y microsphere radioembolization treatment planning
The value of 99mTc-MAA SPECT/CT for lung shunt estimation in 90Y radioembolization: a phantom and patient study
Radioembolization for Hepatocellular Carcinoma: a Comparison on Dual-phase Cone-beam CT, Contrast-enhanced CT (CECT) and 99mTc-macroaggregated albumin-SPECT/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET/CT
Evaluierung von Verteilungsunterschieden zwischen prätherapeutischem 99mTc-MAA SPECT/CT und posttherapeutischem 90Y PET/CT bei der SIRT
Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization
Impact of the dosimetry approach on the resulting 90Y radioembolization planned absorbed doses based on 99mTc-MAA SPECT-CT: is there agreement between dosimetry methods?
Combined quality and dose-volume histograms for assessing the predictive value of 99mTc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer
CT texture features and lung shunt fraction measured using 99mTc-macroaggregated albumin SPECT/CT before trans-arterial radioembolization for hepatocellular carcinoma patients
Correction to: Combined quality and dose-volume histograms for assessing the predictive value of 99mTc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer
Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
Korrelation der Parenchym Blood Volume (PBV)-Rotationsangiographie mit der Technecium-99m Macroaggregated Albumin (99mTc-MAA)-SPECT/CT zur Planung der Selektiven Internen Radiotherapie